Lifecore Injectables CDMO
3515 Lyman Blvd.
Chaska, MN 55318
T: (952) 368-4300
cdmo@lifecore.com
W: lifecore.com
LinkedIn: https://www.linkedin.com/company/lifecore-biomedical 

Unsure your filling needs will be fulfilled? Have a complex injectable product or process? We say, “Bring it.”

Lifecore is a U.S.-based Contract Development and Manufacturing Organization specializing in the development, fill/finish, and commercialization of sterile injectables.

With a 40+ year regulatory track record and 20+ commercial products, Lifecore offers end-to-end services with experience spanning straightforward to complex formulations.  We support organizations of all sizes across pre-clinical, clinical, and commercial stages.

Lifecore is also a leading producer of pharmaceutical-grade, non-animal-sourced sodium hyaluronate which is used as an API and excipient.

Why Choose Lifecore?

We’re creative problem solvers who enjoy helping our customers find solutions to complex products and processes.

We don’t have limitations on what we’re willing to consider. We’re flexible when onboarding customer processes, methods, and equipment at our facilities.

Process Development & Fill/Finish Services

• Development, fill and finish of sterile injectables
• Syringes, vials, and cartridges
• Expertise in highly viscous (exceeding 100,000 cP) and complex formulations

• Proven QMS supports drugs, biologics, medical devices, and combination products

Additional Services

• Extensive on-site microbiological, analytical, and physical testing with redundant labs
• ICH stability studies
• Range of labeling, packaging, and serialization options

Sodium Hyaluronate

• Research-grade, pharmaceutical-grade, hydrogels, and custom modifications
• Broad range of average molecular weights for use in R&D, animal/tox studies, clinical studies, and commercial applications
• US DMF approved, EP-certified, and JP-compliant

Videos

Lifecore Injectables CDMO Capabilities Tour https://www.youtube.com/watch?v=luG_iS8gxR4&t=5s

A HOME for Your Molecule

60 Years of Helping Patients

Technical Feature

High-Throughput Sterile Filtration of Highly Viscous Pharmaceutical Formulations

High-Throughput Sterile Filtration of Highly Viscous Pharmaceutical Formulations

Published Articles

EXECUTIVE INTERVIEW – Lifecore Biomedical: Capacity to Keep Pace With Biologics Growth

September 9, 2025

SPECIAL FEATURE – Injection Devices: Faster, Integrated, and Flexible for the IV to SC Transition September 9, 2025

Contributor Cindy H. Dubin speaks with several companies who highlight how device developers are addressing various challenges while still ensuring precise dosage control and patient compliance.

June 4, 2025

SPECIAL FEATURE- Outsourcing Formulation Development & Manufacturing: CDMOs Are Making Their Supply Chains More Resilient & Secure June 4, 2025

Contributor Cindy H. Dubin speaks with many CDMO professionals to get their insights and perspectives on the current state of the industry.

May 7, 2025

SPECIAL FEATURE – PFS & Parenteral Delivery: Innovation Is Focused on Patient-Centric, Smart & Sustainable Solutions May 7, 2025

Contributor Cindy H. Dubin speaks with several innovating companies to discuss trends in PFS as well as advancements in autoinjectors and innovations in parenteral delivery.

February 11, 2025

SPECIAL FEATURE – Analytical Testing – Diverse Demands & Therapies Require Diverse Analyses February 11, 2025

Contributor Cindy H. Dubin highlights how analytical testing has evolved to address diverse pharmaceutical therapeutics in research and development.

Beating the Timeline of a Complex Formulation (Featured in the June 2023 Issue of Drug Development & Delivery)

Unique Challenges for Ophthalmic Customers (Featured in the May 2023 Issue of Drug Development & Delivery)

EXECUTIVE INTERVIEW – Lifecore Biomedical: Capacity to Keep Pace With Biologics Growth